Corporation
Lifestyle
Bio Solution Co.,Ltd. Focuses on Managing the “Placebo Group” in DMOAD Trials… What Is the Strategy to Increase the Likelihood of Clinical Success?
Bio Solution Co.,Ltd.(086820)BioSolution is focusing its R&D efforts on clearly demonstrating the difference in efficacy between the treatment group and the placebo group in the clinical trial for “Sp…
Lifestyle
"CheilWorldwide Lands Sam.3, INNOCEAN WORLDWIDE INC. Lands KT"... Advertising Industry Competes to Attract Non-Affiliated Clients
CheilWorldwide(030000)·INNOCEAN WORLDWIDE INC.(214320)· #HSAD · #Daehong Planning: The “Big Four” of the domestic advertising industry are stepping up their efforts to secure non-affiliated clients (a…
Lifestyle
“Sell in the U.S. First, Then in Korea”… The Spread of K-Food “Reverse Launches”
“I was curious because BTS enjoyed it so much, but since it wasn’t available in Korea, I waited for it to be released.”
BTS members V (from left), RM, and Jimin are introducing ARIH products. (Phot…
Lifestyle
Kim Jae-jin, CEO of IoFlow: “We’ve Filed an Appeal Against the Delisting Decision… and Secured a Commitment for the Necessary Investment”
IoFlow is filing an appeal against the delisting decision made by the Korea Exchange’s Corporate Review Committee (CRC). IoFlow maintains that if the appeal is accepted, it will be able to resolve a s…
Lifestyle
JETEMA Co.,Ltd.’s 552 billion won Botox jackpot within reach… “440 billion won is from committed orders”
With JETEMA Co.,Ltd.(216080)having completed its application for marketing authorization in China for the botulinum toxin “JTM201,” the timing for revenue recognition from a supply contract worth appr…
Lifestyle
LG H&H Sells U.S. Avon Business… "Restructuring North American Operations"
LG H&H is set to restructure its North American operations by selling The Avon Company, a subsidiary long considered a “troubled asset.” LG H&H(051900)LG Corp.’s North American subsidiary (LG H&H USA,…
Lifestyle
Single-Substance K-Bio Hits Record High... Behind the 'Jackpot' Was Lim Ju-hyun of H.O.P.
HanmiPharm(128940)Hanmi Group has rewritten the history of domestic pharmaceutical and biotech technology exports with a single obesity drug candidate. The deal, worth up to $2.3 billion—including an …
Lifestyle
HanmiPharm Signs Exclusive License Agreement with Genentech for Innovative New Obesity Drug
HanmiPharm(128940)announced on the 24th that it has signed an exclusive licensing agreement with Genentech, a subsidiary of the Roche Group, for “HM17321 (UCN2 analog),” an innovative new drug candida…
Lifestyle
KMPHARMACEUTICAL Co.,Ltd. Gains Momentum from Global Expansion… Set to Surpass 20 Billion Won in Annual Revenue
Life care specialist KMPHARMACEUTICAL Co.,Ltd.(225430)has emerged from a prolonged period of stagnant performance and is now on a path of substantial revenue growth. This is the result of tangible out…
Lifestyle
"We Were the Only Ones Who Didn't Know"—'Green Shin Ramyun,' Available Only to Americans [Tasting Report]
I’ll try just about anything and report back to you. I’m interested in not only new products but also products making a comeback. I avoid simple reviews. I’ll also explain why a product is popular and…